Metformin, a commonly prescribed drug for the treatment of type 2 diabetes, has been touted in several recent studies as having the potential to reduce the risk of cancer in people taking it to control their disease.
Metformin (Glucophage) helps control both insulin levels and the amount of glucose produced by the liver. It’s given to people with type 2 diabetes who have not been able to control the disease through lifestyle changes – diet and exercise.
Since type 2 diabetes affects millions of people and those numbers continue to rise – even among children and teenagers – there is a lot of scientific interest directed toward this population. It has been observed that those taking metformin to control their disease also seemed to have less risk for certain cancers.
Moreover, lab studies have shown an association between metformin and its ability to cause the death of cancer cells.